June 23, 2010
Valeant Pharmaceuticals announced that it's Oxsoralen-Ultra (methoxsalen capsules) is available again for the treatment of severe psoriasis.
May 11, 2010
The FDA's Division of Drug Marketing, Advertising, and Communications (DDMAC) has launched the Bad Ad Program, designed to educate healthcare providers about their role in ensuring that prescription drug advertising and promotion is truthful, and not misleading.
February 03, 2010
The FDA has approved Medicis' hyaluronic acid with lidocaine dermal fillers, Restylane-L and Perlane-L.
February 02, 2010
The FDA has approved Juvéderm XC (hyaluronic acid and lidocaine [preservative-free] injectable gel, from Allergan) dermal filler for injection into the mid-to-deep dermis for correction of moderate to severe facial wrinkles and folds (eg, nasolabial folds).
December 16, 2009
Celgene announced clinical data from its Phase 2b study of apremilast (CC-10004) in patients with moderate-to-severe plaque-type psoriasis (PSOR-005).